Exelixis Inc Notes Payable, Noncurrent
Exelixis Inc (EXEL) had Notes Payable, Noncurrent of $0 as of 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermNotesPayable · last filed 2017-02-27
- 2016-12-31: Notes Payable, Noncurrent $0.00.
- 2016-09-30: Notes Payable, Noncurrent $0.00.
- 2016-06-30: Notes Payable, Noncurrent $0.00.
- 2016-03-31: Notes Payable, Noncurrent $80.00M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-03 |
| 2016-03-31 | $80.00M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $80.00M 10-K · filed 2017-02-27 |
| 2015-09-30 | $80.00M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $80.00M 10-Q · filed 2015-08-11 |
| 2015-03-31 | $80.00M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $80.00M 10-K · filed 2016-02-29 |
| 2014-09-30 | $80.00M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $80.06M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $80.22M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $80.33M 10-K · filed 2015-03-02 |
| 2013-09-30 | $80.76M 10-Q · filed 2013-10-30 |
| 2013-06-30 | $81.13M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $81.61M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $82.09M 10-K · filed 2014-02-20 |
| 2012-09-30 | $82.89M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $83.68M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $84.47M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $85.26M 10-K · filed 2013-02-21 |
| 2011-09-30 | $85.79M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $86.57M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $87.31M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |